baber/WOPTO huggingface dataset:
Patent GB-1303366-A (GB)
IPC: F04B9/14
Filed: 1970-12-08
Abstract: 1303366 Piston dispensers P C COX (MASTIC APPLANCES) Ltd 8 Dec 1971 [8 Dec 1970] 58269/70 Heading F1R A dispenser for a viscous material, e.g. mastic caulking material, comprises a holder 10 for a cartridge 2, a threaded rod 12 and a nut 11 through which the rod passes and which is mounted on the holder 10 in a manner permitting inversion of the nut and rod with respect to the holder. The holder 10 is a generally U-shaped length of wire having its free ends formed into closed eyes 23, 24, and the nut 11 is provided with trunnions 18, 19 rotatably mounted within the eyes. The bight of the U-shape is looped to form a resilient mouth (27), Fig.3, (not shown), to receive the neck 6 of the cartridge. The nut may alternatively be carried in a recess in the holder so that when the cartridge is empty the nut and rod can be slipped out of the holder, inverted, and then re-positioned. The rod 12 is provided with knobs 31, 32 at its ends which fit into a plunger 7 within the cartridge, and each knob may be provided with a diametral hole to receive a tommy bar. If the cartridge does not possess a plunger, the ends of the rod 12 carry plungers shaped to seal with the cartridge wall.
Patent GB-1306880-A (GB)
Title: Internal combustion engines
IPC: F02B25/00
Filed: 1970-08-14
Abstract: 1306880 Charging engines; turning gear SIR W G ARMSTRONG WHITWORTH & Co (ENGS) Ltd 18 May 1971 [14 Aug 1970] 39251/70 Headings F1B F1K A main two-stroke I. C. engine 1 which drives an inlet air compressor 8 is started by an engine 2 which drives an auxiliary compressor 13 the output of which can be connected to the delivery of the main engine air compressor to augment  the main engine air supply. The engine 2 is started, e.g. by hand, and drives the auxiliary compressor 13 through clutch 12 whilst the main engine is warmed by the cooling water from engine 2. Clutch 12 is disengaged so that an hydraulic pump 4 drives a motor 5 to crank the main engine until the latter starts. Both engines idle with the clutches 3 and 12 disengaged. When power is required clutch 12 is engaged and engine 2 is run up to a speed controlled by governor 15. The increased delivery from the compressor 13 opens non-return valve 10 to supply air to the output of the compressor 8. Clutches 3 and 12 may be replaced by dog clutches.
Patent GB-1321803-A (GB)
Title: Article handling apparatus
IPC: B65G47/68
Filed: 1971-03-02
Abstract: 1321803 Endless conveyers L WORTLEY 2 March 1972 [2 March 1971] 5843/71 Heading B8A Tin cans &c. fed randomly on to an endless conveyer 10 driven at a first speed are transferred into single file on an endless conveyer 12 driven at a second faster speed and extending transversely of and in a plane perpendicular to the plane containing the conveyer 10. A magnet 18 is associated with the conveyer 12 to hold the cans thereto for delivery to further apparatus (not shown). A dead plate (not shown) may be placed over the conveyer 10 adjacent the conveyer 12 to withhold the cans on the conveyer 10 until cans on the converyer 12 are clear of their path. The conveyer 12 may be reversible to deliver the cans on either side or may be formed by two conveyers driven in opposite direction to deliver the cans to both sides.
Patent GB-1330295-A (GB)
Title: Measurement of electrolytic conductivity
IPC: G01N27/416
Filed: 1969-11-12
Abstract: 1330295 Measuring conductivity PLESSEY CO Ltd 7 Dec 1970 [12 Nov 1969] 55485/69 Heading G1N In a conductivity cell C of the kind comprising two current electrodes 1, 4 supplied with a direct current i and two voltage electrodes 2, 3 spaced apart between the current electrodes, a further current electrode 5 is provided to prevent current flow externally of the cell. The cell may be used to measure salinity.
Patent GB-1339561-A (GB)
Title: Electric cables
IPC: H01B7/18
Filed: 1970-05-22
Abstract: 1339561 Cables CONNOLLYS (BLACKLEY) Ltd 21 May 1971 [22 May 1970] 24940/70 Heading H1A A cable comprises a core 1 made up of a plurality of conductors 2 having individual insulation 3 and a paper lapping 4, a buffer layer 5 of a cellular plastics compound and a plastics sheath 6 the thickness of the buffer layer being 1 to 5 times that of the sheath. The core may be filled with a water impermeable medium e.g. petroleum jelly, and a water barrier, e.g. a metal foil, may be present between the buffer layer and the sheath or within the thickness either of the buffer layer or the sheath. The sheath and the buffer layer may respectively comprise the following: ethylene propylene copolymer (EPC) and cellular polyethylene; EPC and polyvinylchloride (PVC); polypropylene and high density polyethylene; or PVC and low density polyethylene. The buffer layer may be lapped on to the core in the form of pre-expanded tape or extruded directly on to the core and expanded by gas-injection or by a chemical blowing agent e.g. oxybisbenzene sulphanhydrazide polyethylene.
Patent GB-1340498-A (GB)
Title: Process for the preparation of mordenite
IPC: C01F/
Filed: 1971-04-19
Abstract: 1340498 Synthetic mordenite SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ NV 19 April 1971 [3 April 1970] 15942/70 Heading C1A Mordenite is prepared by heating an aqueous mixture comprising amorphous silica-alumina and one or more sodium compounds, in which process at least 70 mol. per cent of the sodium present in the starting mixture expressed as Na 2 O originates from sodium salts of polybasic acids having a pK value for the highest dissociation step measured at 18‹ C., which is larger than 10 and in which process the following relation exists between the Na 2 O/Al 2 O 3  molar ratio (m) in the starting mixture and the applied reaction temperature (t) which amounts at most to 160‹ C.: m=8À3-0À06(t-100)Œ2À3. Examples of suitable inorganic acids are arsenic acid, orthoboric acid, carbonic acid and phosphoric acid. The amorphous silica-alumina preferably has a silica/alumina molar ratio between 9À5 and 12À5 and is preferably either a cogel of aluminium hydroxide on silica hydrogel or a cogel of a commercial silica-alumina cracking catalyst. Preferably the reaction is carried out at 95‹ to 155‹ C. with agitation in an autoclave at autogeneous pressure. The crystals of mordenite separated from the mother liquid are washed with water and dried at 100‹ to 200‹ C.
Patent GB-1347307-A (GB)
Title: Liqueid level indicators
IPC: G01F23/30
Filed: 1971-09-28
Abstract: 1347307 Liquid level indication WESTLAND AIRCRAFT Ltd 6 Sept 1972 [28 Sept 1971] 45149/71 Heading G1H In a liquid level indicating means the liquid level 17 in a first container 11 is indicated  relating to a datum level during changes in attitude by a pointer 13 and float 15, or an electrically operated liquid level response  device, Fig. 3 (not shown), in an upper second container 12. In the electrically operated means leads are connected to a strip indicator in the second container so that an indicator needle is moved over a transparent surface as the attitude of the containers change. In a further embodiment, Figs. 6 and 7, (not shown), two electrically operative response means, one for the upper tank and one for the lower, indicate the level on a single transparent surface.
Patent GB-1351156-A (GB)
Title: Apparatus for forming filling and sealing a synthetic resin  tetrahedral container
IPC: B65B43/04
Filed: 1971-07-29
Abstract: 1351156 Making tetrahedral containers S IZUMI 29 July 1971 35830/71 Heading B5D [Also in Division B8] To make tetrahedral container 8, a plastics collapsed tubular web 2 having edge creases 2<SP>1</SP>, 2<SP>11</SP> is fed to a device 4 which re-collapses the tube 2 such that the creases 2<SP>1</SP>, 2<SP>11</SP> are superimposed near the centre line of the recollapsed tube, one end of the tube is sealed by a sealer 29, and a length of tube is severed by a knife 28 so that the unsealed end of the tube-length reverts to its original configuration to form a tetrahedral container. The tube 2 is pulled from a roll 1 by rollers 24, 25. The device 4 may comprise a series of pairs of spaced grooved rollers 16-19, 16<SP>1</SP>-19<SP>1</SP>, the spacing between which decreases. Alternatively (Figs. 9-11) the device 4 comprises two opposed U-section plows of decreasing separation.
Patent ID-27517-A (ID)
Inventor: VIGELAND BENT
IPC: B01D71/02
Filed: 1998-06-05
Abstract: The present invention relates to a dense single-phase membrane having both high ionic and electronic conductivity and capable of separating oxygen from an oxygen containing gaseous mixture, where the membrane comprises a mixed metal oxide material with interstitial oxygen excess represented by the formula AyA'y'A''y''BxB'x'B''x''B'''x'''O4+delta, where A, A' and A'' are chosen from group 1, 2 and 3 and the lanthanides; and B, B', B'' and B''' are chosen from the transition metals according to the periodic table of the elements adopted by IUPAC wherein 0<=y<=2, 0<=y'<=2, 0<=y''<=2, 0<=x<=1, 0<=x'<=1, 0<=x''<=1, 0<=x'''<=1, and x and y each represents a number such that y+y'+y''=2, x+x'+x''+x'''=1, and delta is a number where 0<=delta<1 quantifying the oxygen excess. Furthermore, the invention relates to a use of the membrane for production of pure oxygen, oxygen enrichment of a sweep gas for fossil energy conversion, for synthesis gas production and for production of oxygen for application in any catalytic or non-catalytic processes wherein oxygen is one of the reactants.
Patent ID-29452-A (ID)
Inventor: TURNER STEVEN RONALD
IPC: A61K31/5377
Filed: 1999-12-22
Abstract: The present invention provides a compound of formula IWherein R1 is C1-7 alkyl, optionally substituted by hydroxy or NR4R5; R2 is C1-7 alkyl substituted by hydroxy or NR4R5; R3 is H, F or C1-7 alkoxy; R4 and R5 together with N are a 5- or 6-membered heterocyclic moiety having 1-3 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur in which sulfur may be substituted by one (1) or two (2) oxygen atoms; and pharmaceutically acceptable salts thereof Compounds of formula I of the present invention are useful as antiviral agents.
Patent IL-112665-A (IL)
Title: 5-Substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
IPC: A61K31/40
Filed: 1995-02-16
Abstract: The disclosed hexenoic acid side-chain derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil, including immune, inflammatory, tumor, proliferative, viral or psoriatic disorders.
Patent IL-112674-A (IL)
Title: Sustained release liquid aqueous ophthalmic delivery system and liquid aqueous ophthalmic pharmaceutical composition both containing the polymer chitosan
IPC: A61K9/00
Filed: 1995-02-16
Abstract: Disclosed is a sustained release liquid aqueous ophthalmic delivery system and a method of providing a slow and sustained release of ophthalmic treating agents to the eye of a mammal which comprises administering to the eye of a said mammal an effective amount of a homogeneous liquid aqueous ophthalmic pharmaceutical composition, of pH between about 3.0 and about 6.2, which is adminstrable in drop form and which comprises an ophthalmically effective concentration of a said ophthalmic treating agent and about 0.05% to about 10% by weight of the polymer chitosan; said polymer consisting essentially of (A) monomeric  beta (1->4)-D-glucosamine linked units and of (B) monomeric  beta (1->4)-D-glucosamine linked units which are scattered randomly in the molecule of the polymer, the numerical proportions of A and B being from about 60 to about 99% of A and about 1 to about 40% of B, the viscosity rating being from about 3 to about 3000 cps; in which method, upon contact with the higher pH of the ocular fluid, said liquid formulation is converted to a stiff gel from which the ophthalmic treating agent is slowly released over a prolonged period of time.
Patent IL-112847-A (IL)
Title: Isoxazoline compounds as inhibitors of tnf release
IPC: A61P35/00
Filed: 1995-03-02
Abstract: This invention relates to isoxazoline compounds which are inhibitors of tumor necrosis factor (TNF). The isoxazoline compounds are useful for inhibiting TNF in a mammal in need thereof and in the treatment or alleviation of inflammatory conditions or disease, including but not limited to rheumatoid arthritis, osteoarthritis, asthma, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis and inflammatory bowel disease, sepsis, septic shock, tuberculosis, graft versus host disease and cachexia associated with AIDS or cancer. This invention also relates to pharmaceutical compositions useful therefor comprising such compounds.
Patent IL-129944-A (IL)
Title: Drilling device
IPC: E21B44/00
Filed: 1997-11-18
Abstract: Drilling device, of the type possessing a drilling unit of which the tool is driven to rotate from a hydraulic motor associated with an advancing device enabling a bearing force of the drilling unit on the ground to be created, the various actuating members being driven from at least one hydraulic pump via a set of hydraulic distributors and a set of tubes, such as hoses, the two feed tubes of the advancing device of the drilling system being equipped with a switch for reversing the direction of circulation of the fluid in the advancing device. Mounted on one of the branches of the feed circuit of the hydraulic motor for driving the tool in rotation is a fluid measurement device constantly supplying information to a compensation device for subtracting the calculated loss of head created by all the members of the circuit between two known points in that circuit, situated on either side of the motor, from the pressure difference measured between those same two points, the result of this operation actuating the switch for reversing the direction of circulation of the advancing fluid if the value exceeds a given value.
Patent IL-130477-A (IL)
Title: Process for amplifying nucleic acid
IPC: C12Q1/6853
Filed: 1999-06-14
Abstract: A process for linearly amplifying a specific nucleic acid sequence comprising the steps of: providing: said specific nucleic acid sequence, an initiial primer or a nucleic acid construct comprising two segments, (A) a first segment (i) being substantially complementary to a first portion of said specific nucleic acid sequence and (ii) capable of template-dependent first extension, and (B) a second segment being (i) substantially non-identical to said first segment, (ii) substantially identical to a second portion of said specific nucleic acid sequence, (iii) capable of binding to a complementary sequence of said second segment and (iv) capable of providing for subsequent binding of a first segment of a second primer or nucleic acid construct to said first portion of said specific nucleic acid sequence under isostatic or limited cycling conditions, such that a second primer extension is produced and displaces a first primer extension; and substrates, buffer and a template-dependent polymerizing enzyme; and incubating said specific nucleic acid sequence and said novel primer or nucleic acid construct in the presence of said substrates, buffer and template-dependent polymerizing enzyme under isostatic or limited cycling conditions; thereby linearly amplifying said specific nucleic acid sequence.
Patent IL-145630-A (IL)
Title: Method for a programmed controlled ovarian stimulation protocol
IPC: A61K31/57
Filed: 2001-09-25
Abstract: A method of therapeutic management of infertility by programming of controlled ovarian stimulation and assisted reproductive procedures is disclosed containing the steps of a) suppression of premature ovulation with an LHRH-antagonist in controlled ovarian stimulation and assisted reproductive techniques with multiple follicle and oocyte development; b) programming the start of controlled ovarian stimulation by the administration to a patient of progestogen only-preparations or, alternatively, combined oral contraceptive preparations; c) exogenous stimulation of the ovarian follicle growth; d) ovulation induction with HCG, native LHRH, LHRH-agonists or recombinant LH; and e) application of assisted reproduction techniques, especially of IVF, ICSI, GIFT, ZIFT or by intrauterine insemination by sperm injection, wherein onset of the patient's menstrual cycle and of controlled ovarian stimulation are programmed in order to perform oocyte pickup and fertilization procedures during Mondays to Fridays.
Patent IL-147688-A (IL)
Title: Medicaments comprising roflumilast and uses thereof
IPC: A61K45/06
Filed: 2002-01-17
Abstract: The invention relates to the combined administration of PDE inhibitors and ² 2  adrenoceptor agonists for the treatment of respiratory tract disorders.
Patent IL-151629-A (IL)
Title: Ballistics fire control solution process and apparatus for a spin or fin stabilised projectile
IPC: F41G3/14
Filed: 2002-09-05
Abstract: A ballistics fire control system for a spin or fin stabilized projectile is provided with means which are operated such that the closest point of approach between a fired projectile and a target is taken to be at the instant the projectile velocity vector (6) is orthogonal to the position error vector (13) between the projectile and target in accordance with the relationship: Vp.(PP-PF)=0 where Vp is the projectile velocity vector, PP is the projectile trajectory or position vector, PF is the target future position vector, . is the vector dot product and (PP-PF) is the position error vector.
Patent IL-154716-A (IL)
Title: Method for controlling of a shaped charge jet according to the missile speed, and missile
Inventor: HELANDER JYRKI
IPC: F42B12/14
Filed: 2003-03-03
Abstract: The present invention relates to a method for attacking a target by means of a missile ( 1 ) with at least one shaped charge, the direction of action of which differs from the direction of flight of the missile, and to a missile ( 1 ) comprising at least one shape charge ( 2 ) arranged to act in a direction ( 4 ) that differs from the direction of flight ( 5 ) of the missile. The shaped charge jet is corrected for the speed of the missile ( 1 ). According to the invention, the correction of the shaped charge jet is adjustable, whereby the lethality of the missile can be achieved within a wide range of speeds of the missile.
Patent IL-157147-A (IL)
Title: Internet session initiation on personal cellular telecommunications devices and customization protocol therefor
IPC: H04M1/72445
Filed: 2003-07-29
Abstract: A customizable client application capable of running on all seven classes of Internet-enabled personal cellular telecommunications devices whose Internet browser launching capabilities range from being Class 0 non Internet-enabled to Class 6 automatic Internet browser launching. The client application facilitates minimum subscriber intervention for Internet session initiation from an Internet session option of an interactive display message.
Patent IL-160516-A (IL)
Title: 3 , 4 - epoxy alkanoic acid ester, fragant component, fragrant product containing them and application of the compounds
Inventor: WILLIAMS ALVIN SCOTT
IPC: A61K8/00
Filed: 2004-02-23
Abstract: The present invention relates to the perfume industry. It concerns more particularly a compound of formula <CHEM> wherein R represents a linear, branched or cyclic C1-3 hydrocarbon group, and the wavy line indicates that the substituents on the epoxide moiety may have a cis or trans configuration, or a mixture of compounds of formula (I). The compounds of formula (I), or a mixture thereof, are useful as perfuming ingredients.
Patent IL-175235-A (IL)
Title: Use of biocompatible polymers for the preparation of a composition or a medical device
IPC: A61K31/737
Filed: 2006-04-26
Abstract: Using biocompatible polymers (I), containing carboxy and O- or N-sulfonate substituents, in the production of pharmaceutical, dermatological or cosmetic compositions (A) or medical devices (B) for the prevention, alleviation and/or treatment of (or protection of tissue against) discomfort, distress, pruritis, irritation and/or pain, is new. The use of biocompatible polymers of formula (I) in the production of pharmaceutical, dermatological or cosmetic compositions (A) or medical devices (B) for the prevention, alleviation and/or treatment of (or protection of tissue against) discomfort, distress, pruritis, irritation and/or pain. A aX xY y (I) A : monomer; X : RCOOR'; Y : O- or N-sulfonate group attached to A, of formula -ROSO 3R' or -NRSO 3R'; R : linear or branched, saturated or unsaturated aliphatic hydrocarbon chain (optionally containing one or more aromatic rings); R' : H or a cation; a : number of monomer units; x : degree of substitution of the monomers A by X; and y : degree of substitution of the monomers A by Y. ACTIVITY : Dermatological; Antipruritic; Analgesic; Vulnerary; Ophthalmological; Auditory; Antiinflammatory; Antiallergic; Antiulcer; Neuroprotective; Antipsoriatic; Antiasthmatic; Osteopathic; Antiarthritic; Gastrointestinal-Gen. Typically sunburn was treated using a polymer (Ia) consisting of dextran of molecular weight 2 kD which had been carboxymethylated (degree of substitution 0.4-0.5) and O-sulfated (degree of substitution 0.7-1). A solution of (Ia) (100 Microg/ml) in physiological saline containing methyl cellulose (in a amount sufficient to give a thin pasty consistency) was applied to the affected areas. Pain was alleviated within 10-30 minutes, and did not reappear the next day. MECHANISM OF ACTION : None given.
Patent IL-178604-A (IL)
Title: Method of controlling and analysing communications in a telephone network
IPC: H04W24/00
Filed: 2006-10-15
Abstract: The invention relates to a method and system for controlling and analyzing cellular radio communications exchanged between mobile terminals and base stations BTS. The invention is characterized in that a dummy mobile terminals and base stations BTS. The invention is comprising a dummy mobile telephone network RRTM_F comprising a dummy base station BTS_F and a dummy mobile terminal MS_F are inserted into the real network RRTM_R, said dummy network being responsible for the decoding and transparent synchronous relaying of messages exchanged between the real network and the real mobile as well as real mobile access control from the real network or the dummy network.
Patent JP-S5325471-A (JP)
Title: El ectronic watch
Inventor: TANAKA KOJIROU
IPC: G04G9/00
Filed: 1976-08-20
Abstract: PURPOSE:To make a watch smaller in size or multiple functional by driving and controlling the active element of a driver for LEDs with the high voltage by a boosting circuit.
Patent JP-S58218123-A (JP)
Title: Manufacture of wafer with marking for grinding
Inventor: KARAKI TOSHIROU
IPC: H01L21/306
Filed: 1982-06-11
Abstract: PURPOSE:To simplify the amount of specified grinding and make it possible to detect it exactly by performing anisotropic etching on a single crystal wafer and forming a marking for grinding that consists of minute protrusions at the bottom of a formed groove. CONSTITUTION:A mask 2 is covered on the face on which grinding of a single crystal Si wafer 1 is made and on the face that is opposite to it. When anisotropic etching is conducted with a water solution of KOH or NaOH, etc. to which for instance isopropyl alcohol, isobutyl alcohol, isoamyl alcohol, etc. single crystal Si islands are separated, and grooves 3 are formed with mirror face, and at the same time many grinding marks 4 that consist of minute pyramid- shaped protrusions with height of several mum-several tens mum can be formed at the bottom of the groove 3. Next, after the mask is removed and an oxidation film (dielectric film) 5 is formed, polycrystalline Si or a different material is stacked on it and the next grinding-process is conducted.
Patent JP-S5325848-A (JP)
Title: Temperature abnormality observation device
Inventor: YOKOUCHI TOSHIO
IPC: H02H7/00
Filed: 1976-08-24
Abstract: PURPOSE: To sense out temperature's condition and abnormality of electric motor etc. accurately even under light loading time. 
     COPYRIGHT: (C)1978,JPO&Japio